Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heloisa P Soares

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Expert Opinion on Biological Therapy|April 7, 2010
Velimogene aliplasmidHeloisa P Soares, Jose Lutzky
Cancer Treatment Reviews|May 27, 2006
Salvage radiotherapy increases survival in people with residual disease after chemotherapy for advance diffuse large cell lymphomaAmbuj Kumar, Heloisa P Soares
Cancers|October 23, 2021
Quality of Life and Symptom Management in Advanced Biliary Tract CancersLindsay A Hunter, Heloisa P Soares
Cancer Treatment Reviews|November 4, 2006
Evidence profiles for breast cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Current Opinion in Oncology|May 4, 2016
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trialsMauro Cives, Heloisa P Soares, Jonathan Strosberg
Cancer Treatment Reviews|August 18, 2006
What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harmsBenjamin Djulbegovic, Heloisa P Soares, Ambuj Kumar
Cancer Treatment Reviews|August 22, 2006
Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidenceAmbuj Kumar, Heloisa P Soares, Benjamin Djulbegovic
Cancer Treatment Reviews|September 30, 2006
Evidence profiles for lung cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Molecular Cancer Therapeutics|October 18, 2014
Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistanceEnrique Rozengurt, Heloisa P Soares, James Sinnet-Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groupsAmbuj Kumar, Heloisa P Soares, Lodovico Balducci, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|April 7, 2010
Velimogene aliplasmidHeloisa P Soares, Jose Lutzky
Cancer Treatment Reviews|May 27, 2006
Salvage radiotherapy increases survival in people with residual disease after chemotherapy for advance diffuse large cell lymphomaAmbuj Kumar, Heloisa P Soares
Cancers|October 23, 2021
Quality of Life and Symptom Management in Advanced Biliary Tract CancersLindsay A Hunter, Heloisa P Soares
Cancer Treatment Reviews|November 4, 2006
Evidence profiles for breast cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Current Opinion in Oncology|May 4, 2016
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trialsMauro Cives, Heloisa P Soares, Jonathan Strosberg
Cancer Treatment Reviews|August 18, 2006
What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harmsBenjamin Djulbegovic, Heloisa P Soares, Ambuj Kumar
Cancer Treatment Reviews|August 22, 2006
Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidenceAmbuj Kumar, Heloisa P Soares, Benjamin Djulbegovic
Cancer Treatment Reviews|September 30, 2006
Evidence profiles for lung cancer: benefit/harms data based on the totality of randomized evidenceHeloisa P Soares, Ambuj Kumar, Benjamin Djulbegovic
Molecular Cancer Therapeutics|October 18, 2014
Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistanceEnrique Rozengurt, Heloisa P Soares, James Sinnet-Smith
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groupsAmbuj Kumar, Heloisa P Soares, Lodovico Balducci, et al.
Pageof 7